Hemodynamic effects of heart rate lowering in patients admitted for acute heart failure: the RedRate-HF Study (Reduction of heart Rate in Heart Failure). Issue 2 (February 2023)
- Record Type:
- Journal Article
- Title:
- Hemodynamic effects of heart rate lowering in patients admitted for acute heart failure: the RedRate-HF Study (Reduction of heart Rate in Heart Failure). Issue 2 (February 2023)
- Main Title:
- Hemodynamic effects of heart rate lowering in patients admitted for acute heart failure: the RedRate-HF Study (Reduction of heart Rate in Heart Failure)
- Authors:
- Mortara, Andrea
Rossi, Jessica
Mazzetti, Simone
Catagnano, Francesco
Cavalotti, Cristina
Malerba, Gianluigi
Vecchio, Chiara
Morandi, Fabrizio
Nassiacos, Daniele
Oliva, Fabrizio - Abstract:
- Abstract : Background: In patients admitted for acute heart failure (HF) indication for drugs which reduce the heart rate (HR) is debated. The multicentre prospective study Reduction of heart Rate in Heart Failure (RedRate-HF) was designed to analyse the hemodynamic effects of an early reduction of HR in acute HF. Methods: Hemodynamic parameters were recorded by using the bioimpedance technique, which was shown to be accurate, highly reproducible and sensitive to intra-observer changes. Lowering HR was obtained by ivabradine 5 mg bd, given 48–72 h after admission on the top of optimized treatment. Patients were followed at 24, 48, 72 h after drug assumption and at hospital discharge. Results: Twenty patients of a mean age of 67 ± 15 years, BNP at entry 1348 ± 1198 pg/ml were enrolled. Despite a clinical stabilization, after 48–72 h from admission, HR was persistently >70 bpm. Ivabradine was well tolerated in all patients with a significant increase in RR interval from 747 ± 69 ms at baseline to 948 ± 121 ms at discharge, P < 0.0001. Change in HR was associated with a significant increase in stroke volume (baseline 73 ± 22 vs. 84 ± 19 ml at discharge, P = 0.03), and reduction in left cardiac work index (baseline 3.6 ± 1.2 vs. 3.1 ± 1.1 kg/m 2 at discharge, P = 0.04). Other measures of heart work were also significantly affected while cardiac output remained unchanged Conclusion: The strategy of an early lowering of HR in patients admitted for acute HF on top of usual careAbstract : Background: In patients admitted for acute heart failure (HF) indication for drugs which reduce the heart rate (HR) is debated. The multicentre prospective study Reduction of heart Rate in Heart Failure (RedRate-HF) was designed to analyse the hemodynamic effects of an early reduction of HR in acute HF. Methods: Hemodynamic parameters were recorded by using the bioimpedance technique, which was shown to be accurate, highly reproducible and sensitive to intra-observer changes. Lowering HR was obtained by ivabradine 5 mg bd, given 48–72 h after admission on the top of optimized treatment. Patients were followed at 24, 48, 72 h after drug assumption and at hospital discharge. Results: Twenty patients of a mean age of 67 ± 15 years, BNP at entry 1348 ± 1198 pg/ml were enrolled. Despite a clinical stabilization, after 48–72 h from admission, HR was persistently >70 bpm. Ivabradine was well tolerated in all patients with a significant increase in RR interval from 747 ± 69 ms at baseline to 948 ± 121 ms at discharge, P < 0.0001. Change in HR was associated with a significant increase in stroke volume (baseline 73 ± 22 vs. 84 ± 19 ml at discharge, P = 0.03), and reduction in left cardiac work index (baseline 3.6 ± 1.2 vs. 3.1 ± 1.1 kg/m 2 at discharge, P = 0.04). Other measures of heart work were also significantly affected while cardiac output remained unchanged Conclusion: The strategy of an early lowering of HR in patients admitted for acute HF on top of usual care is feasible and safe. The HR reduction causes a positive increase in stroke volume and may contribute to saving energy without affecting cardiac output. … (more)
- Is Part Of:
- Journal of cardiovascular medicine. Volume 24:Issue 2(2023)
- Journal:
- Journal of cardiovascular medicine
- Issue:
- Volume 24:Issue 2(2023)
- Issue Display:
- Volume 24, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 24
- Issue:
- 2
- Issue Sort Value:
- 2023-0024-0002-0000
- Page Start:
- 113
- Page End:
- 122
- Publication Date:
- 2023-02
- Subjects:
- acute heart failure -- heart rate -- hemodynamic -- ivabradine -- stroke volume
Cardiology -- Periodicals
Cardiovascular system -- Diseases -- Periodicals
Cardiology -- Periodicals
Cardiovascular Diseases -- Periodicals
616.1005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=01244665-000000000-00000 ↗
http://www.jcardiovascularmedicine.com/pt/re/jcm/home.htm ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.2459/JCM.0000000000001427 ↗
- Languages:
- English
- ISSNs:
- 1558-2027
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4954.867300
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24867.xml